AHR and breast carcinoma: The aminoflavones 5-amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one (NSC-688228) and its prodrug conjugate are AhR ligands that have been evaluated in humans for breast cancer chemotherapy [90,122,123].